Agios presents detailed mitapivat trial results for sickle cell

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Entera Bio presents Phase 1 data on single-tablet EB613 Hisse Senetleri 0 10
A Crinetics presents phase 2 data for CAH treatment atumelnant Hisse Senetleri 0 4
A Upstream Bio presents positive Phase 2 trial data for verekitug Hisse Senetleri 0 4
A Jones Cecilia, Agios Pharmaceuticals CFO, sells $109k in stock Hisse Senetleri 0 18
A Milanova, Agios Pharmaceuticals CCO, sells $113k in stock Hisse Senetleri 0 29
A Form 144 AGIOS PHARMACEUTICALS For: 2 April Hisse Senetleri 0 26
A Form 144 AGIOS PHARMACEUTICALS For: 3 March Hisse Senetleri 0 18
A Agios Pharma shares jump as US FDA expands approval for its blood disorder drug Hisse Senetleri 0 53

Benzer konular

Üst